M M Tanner - JoVE Visualize

Showing results (1-10 of 13) with videos related to

Pageof 2

Sort By:

British Journal of Cancer|November 17, 2001

Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versaS Staff, J J Isola, O Johannsson, et al.

Genes, Chromosomes & Cancer|December 31, 1997

Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regionsM Bärlund, M Tirkkonen, F Forozan, et al.

Genes, Chromosomes & Cancer|June 22, 2000

Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriersS Staff, N N Nupponen, A Borg, et al.

Public Health Reports (Washington, D.C. : 1974)|September 1, 1975

Planning for emergency medical services in BostonJ C Kleinman, M M Tanner, D L Soodalter, et al.

Cytogenetics and Cell Genetics|December 22, 1998

Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17M Bärlund, N N Nupponen, R Karhu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000

Frequent amplification of chromosomal region 20q12-q13 in ovarian cancerM M Tanner, S Grenman, A Koul, et al.

British Journal of Cancer|December 1, 1996

DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumoursF Courjal, M Cuny, C Rodriguez, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995

Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implicationsM M Tanner, M Tirkkonen, A Kallioniemi, et al.

European Journal of Clinical Investigation|November 26, 2003

A functional variant of the iNOS gene flanking region is associated with LAD coronary artery disease: an autopsy studyT A Kunnas, J Mikkelsson, E Ilveskoski, et al.

Cancer Research|August 15, 1994

Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genesM M Tanner, M Tirkkonen, A Kallioniemi, et al.

Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:

Pageof 2

British Journal of Cancer|November 17, 2001

Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versaS Staff, J J Isola, O Johannsson, et al.

Genes, Chromosomes & Cancer|December 31, 1997

Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regionsM Bärlund, M Tirkkonen, F Forozan, et al.

Genes, Chromosomes & Cancer|June 22, 2000

Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriersS Staff, N N Nupponen, A Borg, et al.

Public Health Reports (Washington, D.C. : 1974)|September 1, 1975

Planning for emergency medical services in BostonJ C Kleinman, M M Tanner, D L Soodalter, et al.

Cytogenetics and Cell Genetics|December 22, 1998

Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17M Bärlund, N N Nupponen, R Karhu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000

Frequent amplification of chromosomal region 20q12-q13 in ovarian cancerM M Tanner, S Grenman, A Koul, et al.

British Journal of Cancer|December 1, 1996

DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumoursF Courjal, M Cuny, C Rodriguez, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995

Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implicationsM M Tanner, M Tirkkonen, A Kallioniemi, et al.

European Journal of Clinical Investigation|November 26, 2003

A functional variant of the iNOS gene flanking region is associated with LAD coronary artery disease: an autopsy studyT A Kunnas, J Mikkelsson, E Ilveskoski, et al.

Cancer Research|August 15, 1994

Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genesM M Tanner, M Tirkkonen, A Kallioniemi, et al.

Pageof 2